A Study of Doravirine/Islatravir in Healthy Lactating Females (MK-8591A-061)

Recruiting

Phase 1

Doravirine & IslatravirA Study of Doravirine/Islatravir in Healthy Lactating Females (MK-8591A-061)

Sponsor:

Merck Sharp & Dohme LLC

Code:

NCT07086079

Conditions

Healthy

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Accepted

Interventions

DOR/ISL

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-10-10. This information was provided to ClinicalTrials.gov by Merck Sharp & Dohme LLC on 2025-10-06.